IRONWOOD PHARMACEUTICALS, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $515.6M | $517.8M | $593.4M |
| Jun 2022 | $395.5M | $532.9M | $504.4M |
| Sep 2022 | $395.9M | $591.1M | $574.2M |
| Dec 2022 | $396.3M | $652.4M | $656.2M |
| Mar 2023 | $396.7M | $706.9M | $740.3M |
| Jun 2023 | $397.1M | $-345.7M | $175.3M |
| Sep 2023 | $397.5M | $-323.2M | $110.2M |
| Dec 2023 | $397.9M | $-346.3M | $92.2M |
| Mar 2024 | $398.3M | $-330.5M | $121.5M |
| Jun 2024 | $198.6M | $-321.7M | $105.5M |
| Sep 2024 | $198.8M | $-311.3M | $88.2M |
| Dec 2024 | $199.0M | $-301.3M | $88.6M |
| Mar 2025 | $199.2M | $-334.1M | $108.5M |
| Jun 2025 | $199.3M | $-308.2M | $92.9M |
| Sep 2025 | $199.5M | $-264.2M | $140.4M |
| Dec 2025 | — | $-261.8M | $215.5M |
| Mar 2026 | — | $-217.1M | $220.5M |
| Jun 2026 | — | $-161.8M | $79.1M |